A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants.

Clinical trial NCT07619183 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07619183
Sponsor: Prime Gene Therapeutics Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lichen Simplex Chronicus

Start date: 2026-06-04
Primary completion: 2026-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.